Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, PROGRESSIVE CORP/OH/ insiders sold a net $26.6M of stock across 187 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
36 earlier Form 4 trades (code P or S) here by this insider (36 sales), the last on Sep 24, 2026.
The trade is 4.3% of the 28,806 shares held after it.
No other insider sold within 30 days.
897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer Broz Steven sold about $273.6K of PGR under a 10b5-1 plan on Oct 22, 2026; 897 funds added in the latest 13F quarter.
35 earlier Form 4 trades (code P or S) here by this insider (35 sales), the last on Aug 20, 2026.
The trade is 4.1% of the 30,031 shares held after it.
1 other insider sold within 30 days.
897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer Broz Steven sold about $250.3K of PGR under a 10b5-1 plan on Sep 24, 2026; 1 other insider sold within 30 days and 897 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Jul 27, 2026.
The trade is 7.7% of the 485,437 shares held after it.
2 other insiders sold within 30 days.
897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Griffith Susan Patricia sold about $8.2M of PGR under a 10b5-1 plan on Sep 1, 2026, the largest insider sale at the company since 2024; 2 other insiders sold within 30 days and 897 funds added in the latest 13F quarter.
34 earlier Form 4 trades (code P or S) here by this insider (34 sales), the last on Jul 23, 2026.
The trade is 3.9% of the 31,256 shares held after it.
6 other insiders sold within 30 days.
897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer Broz Steven sold about $268.8K of PGR under a 10b5-1 plan on Aug 20, 2026; 6 other insiders sold within 30 days and 897 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 14, 2025.
The trade is 17.2% of the 42,566 shares held after it.
6 other insiders sold within 30 days.
897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Personal Lines Officer Niederst Lori A sold about $1.5M of PGR on Aug 13, 2026; 6 other insiders sold within 30 days and 897 funds added in the latest 13F quarter.
187 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
PGR planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Broz Steven
Filed 2026-10-22
$273.6K
Broz Steven
Filed 2026-09-24
$250.3K
Griffith Susan Patricia
Filed 2026-09-01
$8.2M
Broz Steven
Filed 2026-08-20
$268.8K
Niederst Lori A
Filed 2026-08-13
$1.5M
PGR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
iShares U.S. Insurance ETF
$57.5M position · as of 2026-06-30
13.6%
Select Insurance Portfolio
$52.1M position · as of 2026-05-31
9.0%
Invesco KBW Property & Casualty Insurance ETF
$18.8M position · as of 2026-05-31
7.8%
MARSHFIELD CONCENTRATED OPPORTUNITY FUND
$84.7M position · as of 2026-05-31
6.8%
Bretton Fund
$7.3M position · as of 2026-06-30
5.8%
NYLIM WMC Enduring Capital Fund
$16.6M position · as of 2026-07-31
4.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mrs. Griffith
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$17.7M
$25.8M
$4.8M
+154%
+129%
2024
$16.4M
$61.1M
$4.3M
+162%
+109%
2023
$15.6M
$49.0M
$4.1M
+73%
+55%
2022
$12.7M
$48.5M
$3.2M
+41%
+40%
2021
$14.5M
$26.4M
$3.7M
+11%
+18%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $26.6M sold by insiders over 180 days, 897 funds added last quarter, 2 House member(s) bought in 12 months, disclosed weeks after the trade, $10.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$91.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM PGR
FY Dec 2025
$87.7B
FY Dec 2024
$75.4B
FY Dec 2023
$62.1B
FY Dec 2022
$49.6B
FY Dec 2021
$47.7B
Jun 2026
$23.6B
Mar 2026
$22.2B
Dec 2025
$22.7B
Sep 2025
$22.5B
Jun 2025
$22.0B
Mar 2025
$20.4B
Dec 2024
$20.3B
Sep 2024
$19.7B
At each fiscal year end
Single quarter
Net margin, TTM
+12.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM PGR
FY Dec 2025
+12.9%
FY Dec 2024
+11.3%
FY Dec 2023
+6.3%
FY Dec 2022
+1.5%
FY Dec 2021
+7.0%
Jun 2026
+14.0%
Mar 2026
+12.7%
Dec 2025
+13.0%
Sep 2025
+11.6%
Jun 2025
+14.4%
Mar 2025
+12.6%
Dec 2024
+11.6%
Sep 2024
+11.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$16.0B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM PGR
FY Dec 2025
$17.2B
FY Dec 2024
$14.8B
FY Dec 2023
$10.4B
FY Dec 2022
$6.6B
FY Dec 2021
$7.5B
Jun 2026
$3.5B
Mar 2026
$4.3B
Dec 2025
$3.0B
Sep 2025
$5.1B
Jun 2025
$3.9B
Mar 2025
$5.1B
Dec 2024
$2.9B
Sep 2024
$4.6B
At each fiscal year end
Single quarter
Debt to equity
0.00x
current debt only, 2025-12-31 (6 months older than the period end); equity 2026-06-30
Debt to equity PGR
FY Dec 2025
0.00x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
0.00x
FY Dec 2021
0.00x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt PGR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+34.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity PGR
FY Dec 2025
+40.4%
FY Dec 2024
+37.0%
FY Dec 2023
+21.6%
FY Dec 2022
+4.2%
FY Dec 2021
+19.0%
Jun 2026
+34.9%
Mar 2026
+37.9%
Dec 2025
+40.4%
Sep 2025
+34.2%
Jun 2025
+37.3%
Mar 2025
+34.3%
Dec 2024
+37.0%
Sep 2024
+36.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets PGR
FY Dec 2025
+9.9%
FY Dec 2024
+8.7%
FY Dec 2023
+4.8%
FY Dec 2022
+1.0%
FY Dec 2021
+5.0%
Jun 2026
+9.7%
Mar 2026
+9.9%
Dec 2025
+9.9%
Sep 2025
+9.4%
Jun 2025
+9.8%
Mar 2025
+8.5%
Dec 2024
+8.7%
Sep 2024
+8.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital PGR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed PGR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
11.50x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing PGR
FY Dec 2025
11.84x
FY Dec 2024
16.64x
FY Dec 2023
24.21x
FY Dec 2022
110.86x
FY Dec 2021
18.10x
Jun 2026
10.96x
Mar 2026
10.08x
Dec 2025
11.84x
Sep 2025
13.55x
Jun 2025
15.03x
Mar 2025
19.08x
Dec 2024
16.64x
Sep 2024
18.44x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value PGR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+12.0%
TTM free cash flow over market value at close 2026-10-26
FCF yield PGR
FY Dec 2025
+12.9%
FY Dec 2024
+10.6%
FY Dec 2023
+11.2%
FY Dec 2022
+8.6%
FY Dec 2021
+12.5%
Jun 2026
+12.5%
Mar 2026
+14.1%
Dec 2025
+12.9%
Sep 2025
+11.8%
Jun 2025
+10.5%
Mar 2025
+9.5%
Dec 2024
+10.6%
Sep 2024
+9.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.93x
P/E over trailing EPS growth of 12%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing PGR
FY Dec 2025
0.35x
FY Dec 2024
0.14x
FY Dec 2023
0.05x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.89x
Mar 2026
0.31x
Dec 2025
0.35x
Sep 2025
0.42x
Jun 2025
0.29x
Mar 2025
0.37x
Dec 2024
0.14x
Sep 2024
0.09x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PGR ranks highest on financial health (99th percentile) and profitability (92nd), and lowest on insider conviction (8th), among Insurance peers.
Profitability
92
Inputs
Return on equity+34.9% · 92 pct, sector of 116
Return on assets+9.7% · 92 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 104
Cash flow to debtno debt to cover
Growth
64
Inputs
Revenue growth, YoY+16.3% · 64 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
8
Inputs
Net Form 4 buying (codes P and S), 180d-$17.7M · 16 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
69
Inputs
Funds adding, latest quarter897 · 97 pct, sector of 108
Congress net buyers, 365d0 · 40 pct, universe of 718
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
89
Inputs
Short interest, % of float+1.2% · 85 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+3.0% · 93 pct, sector of 110
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PGR filings, in plain words
Are Progressive insiders buying or selling PGR?
In the 180 days to 2026-10-28, Progressive insiders were net sellers, a net $26.6M across purchases and sales reported on Form 4, by 8 sellers.
Have members of Congress traded PGR?
Yes. In the year to 2026-10-28, 2 House members disclosed buying PGR and 2 House members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-07-17.
Are there planned insider sales of PGR?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $10.5M of stock; the latest, by Broz Steven, was filed 2026-10-22.
Read the full summary
In the 180 days to 2026-10-28, Progressive insiders were net sellers of PGR, a net $26.6M across purchases and sales reported on Form 4 by 8 sellers. 27% of the 15 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 2 members of Congress disclosed buying PGR and 2 members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-07-17. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $10.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.